| Dietary compounds as epigenetic modulating agents in cancer Á Carlos-Reyes, JS López-González, M Meneses-Flores, ... Frontiers in genetics 10, 79, 2019 | 176 | 2019 |
| Adjuvant therapy for stage II colon cancer: ASCO guideline update NN Baxter, EB Kennedy, E Bergsland, J Berlin, TJ George, S Gill, PJ Gold, ... Journal of Clinical Oncology 40 (8), 892-910, 2022 | 127 | 2022 |
| Treatment of malingnant, non-resecanle, epithelial origin esophageal tumours with humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy … M Ramos-Suzarte, P Lorenzo-Luaces, NG Lazo, ML Perez, JL Soriano, ... Cancer biology & therapy 13 (8), 600-605, 2012 | 100 | 2012 |
| Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer SE Rodríguez-Ramírez, A Uribe, EB Ruiz-García, S Labastida, ... Revista de investigación clínica 58 (3), 204-210, 2006 | 92 | 2006 |
| Radiation therapy for rectal cancer: executive summary of an ASTRO clinical practice guideline JY Wo, CJ Anker, JB Ashman, NA Bhadkamkar, L Bradfield, DT Chang, ... Practical radiation oncology 11 (1), 13-25, 2021 | 91 | 2021 |
| SOX9 stem-cell factor: clinical and functional relevance in cancer M Aguilar-Medina, M Avendaño-Félix, E Lizárraga-Verdugo, M Bermúdez, ... Journal of oncology 2019, 2019 | 83 | 2019 |
| Duration of oxaliplatin-containing adjuvant therapy for stage III colon cancer: ASCO clinical practice guideline C Lieu, EB Kennedy, E Bergsland, J Berlin, TJ George, S Gill, PJ Gold, ... Journal of Clinical Oncology 37 (16), 1436-1447, 2019 | 68 | 2019 |
| Dual targeting of ANGPT1 and TGFBR2 genes by miR-204 controls angiogenesis in breast cancer A Flores-Pérez, LA Marchat, S Rodríguez-Cuevas, V Bautista-Piña, ... Scientific reports 6 (1), 34504, 2016 | 68 | 2016 |
| Gene expression predictors in breast cancer: current status, limitations and perspectives C Desmedt, E Ruiz-Garcia, F André European journal of cancer 44 (18), 2714-2720, 2008 | 68 | 2008 |
| Methylation landscape of human breast cancer cells in response to dietary compound resveratrol R Medina-Aguilar, C Pérez-Plasencia, LA Marchat, P Gariglio, ... PLoS One 11 (6), e0157866, 2016 | 67 | 2016 |
| Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C MG Fakih, L Salvatore, T Esaki, DP Modest, DP Lopez-Bravo, J Taieb, ... New England Journal of Medicine 389 (23), 2125-2139, 2023 | 62 | 2023 |
| AngiomiRs: MicroRNAs driving angiogenesis in cancer YM Salinas‑Vera, LA Marchat, D Gallardo‑Rincón, E Ruiz‑García, ... International journal of molecular medicine 43 (2), 657-670, 2019 | 62 | 2019 |
| Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening E Ruiz-Garcia, V Scott, C Machavoine, JM Bidart, L Lacroix, S Delaloge, ... British journal of cancer 102 (3), 462-468, 2010 | 58 | 2010 |
| Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells A Flores-Pérez, LA Marchat, S Rodríguez-Cuevas, VP Bautista, ... BMC cancer 16, 1-12, 2016 | 48 | 2016 |
| Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status … I Alvarado-Cabrero, G Alderete-Vázquez, M Quintal-Ramírez, M Patiño, ... Annals of Diagnostic Pathology 13 (3), 151-157, 2009 | 48 | 2009 |
| MicroRNAs driving invasion and metastasis in ovarian cancer: Opportunities for translational medicine C Palma Flores, R García-Vázquez, D Gallardo Rincón, E Ruiz-García, ... International journal of oncology 50 (5), 1461-1476, 2017 | 42 | 2017 |
| A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer R García-Vazquez, E Ruiz-García, A Meneses Garcia, ... Tumor Biology 39 (6), 1010428317702899, 2017 | 36 | 2017 |
| Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells A Ortega, VM García-Hernández, E Ruiz-García, A Meneses-García, ... Life Sciences 165, 56-62, 2016 | 36 | 2016 |
| Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non‐small cells lung cancer to chemotherapy A Flores‐Pérez, LA Marchat, LL Sánchez, D Romero‐Zamora, ... PROTEOMICS–Clinical Applications 10 (2), 172-182, 2016 | 36 | 2016 |
| Epithelial–mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy L Rojas‐Puentes, AF Cardona, H Carranza, C Vargas, LF Jaramillo, ... Cancer medicine 5 (8), 1989-1999, 2016 | 34 | 2016 |
Leonardo Saúl Lino-SilvaGastrointestinal Pathology, Instituto Nacional de Cancerología de MéxicoVerified email at comunidad.unam.mx
